Albuterol use in respiratory infections
Pro Research Analysisby 
Searched over 200M research papers
Albuterol Use in Pediatric Respiratory Infections
Albuterol in Viral Respiratory Infections: Bronchiolitis and RSV
Albuterol is commonly used in children with respiratory infections like bronchiolitis and respiratory syncytial virus (RSV), but its effectiveness is debated. Studies show that while albuterol is frequently administered to infants and children hospitalized with viral respiratory infections, including human metapneumovirus (HMPV) and RSV, the evidence does not consistently support its routine use. In children with HMPV, a high percentage received albuterol, but there was no difference in hospital length of stay between those who received it and those who did not, suggesting limited benefit for most patients . Similarly, in infants with RSV-induced respiratory failure, only about half showed any improvement in lung function after albuterol, and some even experienced deterioration, indicating that albuterol should be discontinued if no clear benefit is observed .
Randomized controlled trials in infants with mild-to-moderate viral bronchiolitis found no significant difference in symptom resolution or secondary outcomes between those treated with oral albuterol and those given placebo, further questioning its widespread use in this population . However, some studies have reported that nebulized albuterol can provide modest improvements in clinical scores and oxygen saturation in infants with bronchiolitis, though the overall clinical impact remains small .
Albuterol Responsiveness and Assessment Challenges
Determining which children will benefit from albuterol is challenging. Clinical assessments by healthcare providers are not reliable in predicting which ventilated infants with bronchiolitis will respond to albuterol, as shown by poor agreement between clinical impressions and objective pulmonary mechanics measurements . This highlights the need for more objective criteria or testing before continuing albuterol therapy in these patients.
Albuterol’s Anti-Inflammatory Effects in Experimental Models
Experimental studies in animal models of RSV infection suggest that the (R)-enantiomer of albuterol may have stronger anti-inflammatory effects than the racemic mixture or the (S)-enantiomer, potentially offering more benefit in reducing airway inflammation. However, these findings have not yet translated into clear clinical recommendations for routine use in children with viral respiratory infections .
Albuterol and Infection Control Risks
Albuterol administration, especially via nebulization, can pose infection control risks in hospital settings. Outbreaks of respiratory tract colonization and infection with organisms like Burkholderia cepacia have been linked to improper handling of nebulized albuterol, particularly when multi-dose vials are used for multiple patients and infection control practices are not strictly followed. This underscores the importance of proper medication handling and infection control measures to prevent nosocomial infections .
Albuterol in Other Respiratory Settings
In other contexts, such as premedication before tonsillectomy, albuterol has been shown to reduce the risk of perioperative respiratory adverse events, including bronchospasm and oxygen desaturation, suggesting a role for targeted use in specific clinical scenarios outside of viral bronchiolitis .
Albuterol Use During the COVID-19 Pandemic
During the COVID-19 pandemic, concerns about aerosol generation with nebulized albuterol led to increased use of metered dose inhalers (MDIs). Protocols for conserving albuterol MDI supply, such as common canister methods, were implemented successfully without delaying treatment, though further studies on cross-contamination risks are needed .
Conclusion
Albuterol is widely used in children with respiratory infections, but evidence for its routine benefit in viral bronchiolitis and RSV is limited. Its use should be individualized, with therapy discontinued if no clear improvement is observed. Strict infection control practices are essential when administering albuterol, especially in hospital settings. In select situations, such as perioperative care, albuterol may offer clear benefits. Ongoing research and careful clinical assessment are needed to optimize its use in pediatric respiratory infections.
Sources and full results
Most relevant research papers on this topic